JP2019108351A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019108351A5 JP2019108351A5 JP2019032306A JP2019032306A JP2019108351A5 JP 2019108351 A5 JP2019108351 A5 JP 2019108351A5 JP 2019032306 A JP2019032306 A JP 2019032306A JP 2019032306 A JP2019032306 A JP 2019032306A JP 2019108351 A5 JP2019108351 A5 JP 2019108351A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- pharmaceutically acceptable
- acceptable salt
- active ingredient
- oxime
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- BATFHSIVMJJJAF-UHFFFAOYSA-N Morindone Chemical compound OC1=CC=C2C(=O)C3=C(O)C(C)=CC=C3C(=O)C2=C1O BATFHSIVMJJJAF-UHFFFAOYSA-N 0.000 claims 12
- 150000003839 salts Chemical class 0.000 claims 10
- 239000004480 active ingredient Substances 0.000 claims 9
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims 6
- FZENGILVLUJGJX-IHWYPQMZSA-N (Z)-acetaldehyde oxime Chemical compound C\C=N/O FZENGILVLUJGJX-IHWYPQMZSA-N 0.000 claims 4
- KJOVOWDUYRMJEG-UHFFFAOYSA-N 2-hydroxyiminopropan-1-ol Chemical compound OCC(C)=NO KJOVOWDUYRMJEG-UHFFFAOYSA-N 0.000 claims 4
- KLPWJLBORRMFGK-UHFFFAOYSA-N Molindone Chemical compound O=C1C=2C(CC)=C(C)NC=2CCC1CN1CCOCC1 KLPWJLBORRMFGK-UHFFFAOYSA-N 0.000 claims 4
- 229960004938 molindone Drugs 0.000 claims 4
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 claims 3
- -1 aldehyde oxime Chemical class 0.000 claims 2
- 241000282412 Homo Species 0.000 claims 1
- AACZKKTXNWTCOF-UHFFFAOYSA-N N-(2-hydroxyiminopentan-3-ylidene)hydroxylamine Chemical compound CCC(=NO)C(C)=NO AACZKKTXNWTCOF-UHFFFAOYSA-N 0.000 claims 1
- 231100000024 genotoxic Toxicity 0.000 claims 1
- 230000001738 genotoxic effect Effects 0.000 claims 1
- 239000012535 impurity Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261701007P | 2012-09-14 | 2012-09-14 | |
| US61/701,007 | 2012-09-14 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018021784A Division JP2018090604A (ja) | 2012-09-14 | 2018-02-09 | モリンドン及びその塩の製造方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019108351A JP2019108351A (ja) | 2019-07-04 |
| JP2019108351A5 true JP2019108351A5 (https=) | 2020-03-05 |
Family
ID=48050289
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015531913A Expired - Fee Related JP6133427B2 (ja) | 2012-09-14 | 2013-03-15 | モリンドン及びその塩の製造方法 |
| JP2017047064A Expired - Fee Related JP6324567B2 (ja) | 2012-09-14 | 2017-03-13 | モリンドン及びその塩の製造方法 |
| JP2018021784A Pending JP2018090604A (ja) | 2012-09-14 | 2018-02-09 | モリンドン及びその塩の製造方法 |
| JP2019032306A Pending JP2019108351A (ja) | 2012-09-14 | 2019-02-26 | モリンドン及びその塩の製造方法 |
Family Applications Before (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015531913A Expired - Fee Related JP6133427B2 (ja) | 2012-09-14 | 2013-03-15 | モリンドン及びその塩の製造方法 |
| JP2017047064A Expired - Fee Related JP6324567B2 (ja) | 2012-09-14 | 2017-03-13 | モリンドン及びその塩の製造方法 |
| JP2018021784A Pending JP2018090604A (ja) | 2012-09-14 | 2018-02-09 | モリンドン及びその塩の製造方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (6) | US8957206B2 (https=) |
| EP (3) | EP2895175B1 (https=) |
| JP (4) | JP6133427B2 (https=) |
| AU (3) | AU2013316119B2 (https=) |
| CA (3) | CA3170247A1 (https=) |
| ES (1) | ES2643557T3 (https=) |
| MX (4) | MX379124B (https=) |
| WO (1) | WO2014042688A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6133427B2 (ja) * | 2012-09-14 | 2017-05-24 | スパーナス ファーマシューティカルズ インコーポレイテッド | モリンドン及びその塩の製造方法 |
| CN107011237B (zh) * | 2016-01-27 | 2020-04-21 | 合肥立方制药股份有限公司 | 一种改进的吗茚酮的合成方法 |
| US10752586B1 (en) | 2019-02-16 | 2020-08-25 | Lupin Limited | Process for preparation of molindone |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3467755A (en) * | 1966-05-11 | 1969-09-16 | Endo Lab | Compositions and methods for producing sedation and tranquilization with substituted 4,5,6,7- tetrahydro-4-oxindoles |
| US3491093A (en) * | 1967-11-29 | 1970-01-20 | Endo Lab | Derivatives of 5 aminomethyl-4,5,6,7-tetrahydro-4-oxoindoles |
| US3646042A (en) | 1970-02-09 | 1972-02-29 | Velsicol Chemical Corp | Certain n-phenyl n-lower-alkyl-pyridine carboxamides and derivatives thereof |
| US4016281A (en) * | 1975-02-22 | 1977-04-05 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Tetralone and indanone compounds |
| US4065453A (en) | 1976-11-01 | 1977-12-27 | Endo Laboratories, Inc. | Levorotatory molindone and the use as an antidepressant |
| US4707484A (en) * | 1986-11-25 | 1987-11-17 | Hoffmann-La Roche Inc. | Substituted piperidinomethylindolone and cyclopent(b)indolone derivatives |
| US5114936A (en) * | 1990-08-23 | 1992-05-19 | Hoechst-Roussel Pharmaceuticals Incorporated | 6,7-dihydro-3-phenyl-1,2-benzisoxazol-4(5h)-ones and -ols, compositions and pharmaceutical use |
| US5180834A (en) * | 1990-08-23 | 1993-01-19 | Hoechst-Roussel Pharmaceuticals Incorporated | 6,7-dihydro-3-phenyl-1,2-benzisoxazol-4(5h)-ones |
| JP2804364B2 (ja) * | 1990-10-31 | 1998-09-24 | 三井化学株式会社 | オキシム類の製造方法 |
| JP4169562B2 (ja) | 2002-10-09 | 2008-10-22 | 横浜ゴム株式会社 | タイヤ成形用金型及び空気入りタイヤ |
| NZ569317A (en) * | 2005-12-29 | 2010-08-27 | Toyama Chemical Co Ltd | Novel arylamidine derivative, salt thereof and antifungal agent containing those |
| JP2007217353A (ja) * | 2006-02-17 | 2007-08-30 | Sankyo Agro Kk | １，２，３，４−テトラヒドロキノリン化合物 |
| JP6133427B2 (ja) * | 2012-09-14 | 2017-05-24 | スパーナス ファーマシューティカルズ インコーポレイテッド | モリンドン及びその塩の製造方法 |
-
2013
- 2013-03-15 JP JP2015531913A patent/JP6133427B2/ja not_active Expired - Fee Related
- 2013-03-15 CA CA3170247A patent/CA3170247A1/en active Pending
- 2013-03-15 EP EP13714783.1A patent/EP2895175B1/en active Active
- 2013-03-15 EP EP22177217.1A patent/EP4074691A1/en not_active Withdrawn
- 2013-03-15 MX MX2017015078A patent/MX379124B/es unknown
- 2013-03-15 EP EP17180165.7A patent/EP3290403A3/en not_active Withdrawn
- 2013-03-15 WO PCT/US2013/032142 patent/WO2014042688A1/en not_active Ceased
- 2013-03-15 MX MX2017015076A patent/MX382345B/es unknown
- 2013-03-15 AU AU2013316119A patent/AU2013316119B2/en active Active
- 2013-03-15 MX MX2017015070A patent/MX379125B/es unknown
- 2013-03-15 US US13/834,097 patent/US8957206B2/en active Active
- 2013-03-15 ES ES13714783.1T patent/ES2643557T3/es active Active
- 2013-03-15 CA CA3111577A patent/CA3111577C/en active Active
- 2013-03-15 CA CA2884179A patent/CA2884179C/en active Active
- 2013-03-15 MX MX2015003237A patent/MX356357B/es active IP Right Grant
-
2015
- 2015-01-29 US US14/608,262 patent/US9562011B2/en active Active
-
2016
- 2016-11-30 US US15/365,566 patent/US9802893B2/en active Active
-
2017
- 2017-03-13 JP JP2017047064A patent/JP6324567B2/ja not_active Expired - Fee Related
- 2017-07-27 AU AU2017208312A patent/AU2017208312B2/en active Active
- 2017-10-03 US US15/723,515 patent/US10081595B2/en active Active
-
2018
- 2018-02-09 JP JP2018021784A patent/JP2018090604A/ja active Pending
- 2018-08-21 US US16/107,836 patent/US10676432B2/en active Active
-
2019
- 2019-02-26 JP JP2019032306A patent/JP2019108351A/ja active Pending
- 2019-05-09 AU AU2019203270A patent/AU2019203270B2/en active Active
-
2020
- 2020-04-30 US US16/863,020 patent/US11117862B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019108351A5 (https=) | ||
| JP2016536271A5 (https=) | ||
| JP2006520797A5 (https=) | ||
| WO2011076749A3 (en) | Solid pharmaceutical dosage form of ticagrelor | |
| JP2005538121A5 (ja) | 多重遅延放出抗ウイルス物質産物、その使用法と製剤 | |
| FI4088720T3 (fi) | Rimegepantti cgrp-liittyviin häiriöihin | |
| JP2015523407A5 (https=) | ||
| CN110036005A (zh) | 酰胺衍生物及其在药物中的应用 | |
| JP2019194191A5 (https=) | ||
| JP2022163049A5 (https=) | ||
| JP2002526407A5 (https=) | ||
| WO2008023016A3 (en) | Galenic formulations of aliskiren | |
| WO2008116601A3 (en) | Solid dosage forms comprising aliskiren and pharmaceutically acceptable salts thereof | |
| JP2022132411A5 (https=) | ||
| JP2010518138A5 (https=) | ||
| HK1208620A1 (en) | Pharmaceutical composition of entecavir and process of manufacturing | |
| JP2018521007A5 (https=) | ||
| WO2020138791A3 (ko) | 토파시티닙 또는 그의 약제학적으로 허용되는 염을 함유한 서방성 제제 및 그의 제조방법 | |
| JP2020513018A5 (https=) | ||
| JP2016510747A5 (https=) | ||
| JP2006507295A5 (https=) | ||
| WO2009084041A3 (en) | Pharmaceutical compositions of dexibuprofen | |
| WO2022013324A3 (en) | Post-exposure vaccination against viral respiratory infections | |
| RU2016137926A (ru) | Композиции грапипранта и способы их применения | |
| WO2012077968A3 (en) | Complex formulation comprising lercanidipine hydrochloride and valsartan and method for the preparation thereof |